Israeli And American Companies Create Marijuana Inhaler For Sleep
Image by Nikki Casey
By Naomi Zeveloff March 20, 2017
Insomnia sufferers often swear by a puff of marijuana before bed. Now an Israeli company is helping to medicalize the practice with an inhaler that delivers a stable and controlled dose of a cannabis formula that lasts through the night.
i.can.sleep is a joint venture of iCAN:Israel-Cannabis, a group building out the medical marijuana industry in Israel and CannRx, a U.S. corporation that develops medical applications for cannabis.
The joint venture was announced at CannaTech, a conference on medical marijuana happening in Tel Aviv from March 20-22.
“You take a puff or two depending on the dosage and in ten minutes you will be drowsy enough to sleep,” said William Levine of CannRx.
Israel is poised to give final approval to medical marijuana exports in the coming months. According to Kaye, Israel could reap $1 billion in the next two years.
Contact Naomi Zeveloff at [email protected]
Hello, fellow Forward reader! I’m Joel Brown, a Forward reader and supporter for more than 15 years, and currently the chair of the board of directors.
I’m an avid Forward reader because it ticks so many of my essential boxes: excellent journalism, Jewish focus and diverse viewpoints. In today’s political climate, what I most appreciate is the Forward’s independence — made possible by the generosity of its membership.
The Forward is committed to bringing you unbiased, nuanced Jewish news. From my position as board chair, I see an exciting future as we expand our position as the definitive independent voice of contemporary American Judaism.
That’s why I’m paying it Forward, by matching $36,000 of reader gifts. It’s an investment in the Forward’s newsroom, to continue telling the American Jewish story with truth and independence.
— Joel Brown, Forward board chair
Support our mission to tell the Jewish story fully and fairly.
